A Multicenter, Randomized, Controlled Trial of Seprafilm Adhesion Barrier [hyaluronic acid + carmellose] to Reduce Adhesion Formation Following Cesarean Delivery.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmellose (Primary) ; Hyaluronic acid (Primary)
- Indications Post-surgical adhesions
- Focus Therapeutic Use
- 22 Apr 2016 Biomarkers information updated
- 05 Dec 2012 Planned End Date changed from 1 Oct 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 05 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.